Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

BioLine Rx (NASDAQ:BLRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Edgewise Therapeutics Q1 Earnings

Edgewise Therapeutics (NASDAQ:EWTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Why Veru Shares Are Soaring Today Premarket

In a Pre-EUA meeting, FDA said Veru Inc (NASDAQ:VERU) should submit a request for FDA emergency use authorization for sabizabulin in hospitalized COVID-19 patients. The FDA agreed that the Phase 3 COVID-19 study stopped by the Independent Data Monitoring Committee for overwhelming efficacy is sufficient to support the efficacy portion of a request for…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: RAPT Therapeutics Q1 Earnings

RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: SWK Holdings Q1 Earnings

SWK Holdings (NASDAQ:SWKH) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Executives Sell More Than $220M Of 3 Stocks

US stock futures traded higher on this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV

Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

CNBC's Final Trades: Nvidia, Target, Metals & Mining And This Defensive Play

On CNBC’s “Halftime Report Final Trades,” Jon Najarian recommended SPDR S&P Metals & Mining ETF (ARCA: XME), adding “June 50 calls.”

Benzinga

Playboy Parent Shares Pop Post Q1 Results

PLBY Group Inc (NASDAQ:PLBY) reported first-quarter FY21 sales growth of 63% year-on-year to $69.38 million, beating the consensus of $68.53 million. Direct-to-consumer revenue grew 125% Y/Y to $49.6 million. The operating margin was 9.9%, and operating income for the quarter was $6.9 million versus a loss of $(4.5) million last year. Adjusted EBITDA…

Benzinga

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

Benzinga

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

Benzinga

3 Stocks Under $2 Insiders Are Buying

US crude oil futures traded higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, May 11

Reuters

Benzinga

US Court Rules Against Elon Musk's Infamous 'Funding Secured' Tweet

U.S. District Judge Edward Chen of San Francisco ruled that Elon Musk's 2018 tweets of secured funding to take Tesla, Inc (NASDAQ:TSLA) private were inaccurate and reckless, Reuters reports. The court added that "there was nothing concrete" about Saudi Arabia's sovereign wealth fund financing during that time. In 2018, Musk met with Saudi…

Benzinga

Ondas Holdings: Q1 Earnings Insights

Ondas Holdings (NASDAQ:ONDS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Xeris Biopharma Holdings: Q1 Earnings Insights

Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Aspira Womens Health: Q1 Earnings Insights

Aspira Womens Health (NASDAQ:AWH) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Agrify: Q1 Earnings Insights

Agrify (NASDAQ:AGFY) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: PolyPid Q1 Earnings

PolyPid (NASDAQ:PYPD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Pieris Pharmaceuticals Q1 Earnings

Pieris Pharmaceuticals (NASDAQ:PIRS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: PDS Biotechnology Q1 Earnings

PDS Biotechnology (NASDAQ:PDSB) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Evaxion Biotech: Q1 Earnings Insights

Evaxion Biotech (NASDAQ:EVAX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Priority Tech Holdings Q1 Earnings

Priority Tech Holdings (NASDAQ:PRTH) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

1 … 563 564 565 566

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.